Literature DB >> 12564251

Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users.

N M J Wright1, T L Campbell, C N E Tompkins.   

Abstract

This historical control study examines the uptake of two hepatitis B immunisation schedules at an inner city primary care centre for homeless people in Northern England. Originally homeless patients disclosing current or past illicit drug use were offered hepatitis B immunisation. In 1999 a conventional hepatitis B vaccine schedule was offered (immunisations at 0, 1, and 6 months) whereas in 2000 an accelerated schedule was introduced (immunisations at 0, 7 and 21 days). There was an increase in the uptake of hepatitis B vaccination by homeless drug users once the accelerated schedule was introduced. Furthermore, the completion rates for the accelerated vaccination regimen were almost seven times higher than for the conventional one. This indicates that the accelerated hepatitis B schedule should be the regime of choice for patients with a current or past history of drug use.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12564251

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  13 in total

1.  Management of a syphilis outbreak in street sex workers in east London.

Authors:  N Lomax; H Wheeler; S Anaraki; H Anderson; B Goh
Journal:  Sex Transm Infect       Date:  2006-06-28       Impact factor: 3.519

Review 2.  How can health services effectively meet the health needs of homeless people?

Authors:  Nat M J Wright; Charlotte N E Tompkins
Journal:  Br J Gen Pract       Date:  2006-04       Impact factor: 5.386

Review 3.  Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance.

Authors:  K Van Herck; E Leuridan; P Van Damme
Journal:  Sex Transm Infect       Date:  2007-10       Impact factor: 3.519

Review 4.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

Review 5.  Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Authors:  Lisa Maher; Bethany White; Margaret Hellard; Annie Madden; Maria Prins; Thomas Kerr; Kimberly Page
Journal:  Vaccine       Date:  2010-09-09       Impact factor: 3.641

6.  Adherence to hepatitis B virus vaccination at syringe exchange sites.

Authors:  Frederick L Altice; Robert D Bruce; Mary R Walton; Marta I Buitrago
Journal:  J Urban Health       Date:  2005-03-03       Impact factor: 3.671

Review 7.  Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications.

Authors:  Shaili Gupta; Frederick L Altice
Journal:  J Urban Health       Date:  2009-01-28       Impact factor: 3.671

8.  Feasibility of completing an accelerated vaccine series for homeless adults.

Authors:  A M Nyamathi; K Sinha; S Saab; M Marfisee; B Greengold; B Leake; D Tyler
Journal:  J Viral Hepat       Date:  2009-02-24       Impact factor: 3.728

9.  Homelessness and health: what can be done in general practice?

Authors:  Nat M J Wright; Charlotte N E Tompkins; Nicola S Oldham; Debbie J Kay
Journal:  J R Soc Med       Date:  2004-04       Impact factor: 18.000

Review 10.  Strategies to improve vaccination rates in people who are homeless: A systematic review.

Authors:  Laura K McCosker; Asmaa El-Heneidy; Holly Seale; Robert S Ware; Martin J Downes
Journal:  Vaccine       Date:  2022-04-26       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.